Transparency & disclosure
Interactions between AcedrA and healthcare professionals (HCPs) and healthcare organisations (HCOs) can improve patient care, and patients expect transparency around these relationships. We disclose payments and other transfers of value linked to activities such as professional advice on how medicines are used, speaking at medical education meetings, advisory boards, research and educational grants.
International regulations
We follow global transparency laws and codes, including Section 6002 of the U.S. Patient Protection and Affordable Care Act (Open Payments) and France's Bertrand Act.
Local regulations
We comply with the Saudi Food and Drug Authority's transparency guidance (Version 2.1) and report electronically to the Saudi Health Disclosure and Transparency Portal.
Resources and reporting
Our Transparency Policy is part of the AcedrA Code of Conduct. Transparency concerns can be sent to compliance@acedrarx.com.
The Code of Conduct and the disclosure form were downloadable files on the previous website. Upload them to the site (for example in a /files folder) and link them here.